1Pawson T. Protein modules and signalling networks[J].Nature, 1995, 373(6 515): 573.
2Worthen GS, Avdi N, Buhl AM, et al. FMLP activates Ras and Raf in human neutrophils. Potential role in activation of MAP kinase[J].J Clin Invest, 1994,94(2):815.
4Taga T, Kishimoto T.Signaling mechanisms through cytokine receptors that share signaltransducing receptor components[J]. Curr Opin Imnunol, 1995, 7(1): 17.
5Eyers PA, Craxton M, Morrice N, et al. Conversion of SB203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution[J]. Chem Biol, 1998, 5(6) :321.
6Mohammadi M, Mc Mahon G, Sun L, et al. Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors[J]. Science,1997, 276(5 314) :955.
7Jonuleit T, Peschel C, Schwab R, at al. Bcr Abl kinase promotes cell cycle entry of primary myeloid CML cells in the absence of growth factors[J] .Br J Haematol,1998, 100(2): 295.
8Carroll M, Ohno Jones S, Tamura S, et al. CGP57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR ABL, TEL-ABL and TEL-PDGR fusion proteins[J]. Blood, 1997, 90(12): 4 947.
9Le Coutre P. Mologni L, Cleris L, et al. In vivo eradication of human BCR/ABL-positive leukaemia cells with an ABL kinase inhibitor[J].J Natl Cancer Inst,1999, 91(2): 163.
10Ruckemann K, Fairbanks LD, Carrey EA, et al. Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes form healthy humans[J].J Biol Chem, 1998,273(34):21 682.
4[2]Aguiar RC.Therapy-related chronic myeloid leukemia:an epidemiological,clinical and pathogenetic appraisal[J].Leuk Lymphoma,1998,29:17-26.
5[3]Takemoto Y,Hata T,Kamina K,et al.Leukemia is developing after 1311 treatment for thyroid cancer in a patient with Werner's sydrome:Molecular and cytogentic studies[J].Interm Med,1995,34:863-867.
6[4]Ennifer RG, David JT. Elevated levels of transforming growthactor- alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogensis in head and neck cancer[J]. Cancer Res,1993,53:3579
7Gil-Turnes MS, Hay ME, Fenical W. Symbiotic marine bacteria chemically defend crustacean embryosfrom a pathogenic fungus [J ]. Science, 1989, 246(4 926):116.
8Gosheva N, Lorz C, O'Conner S, et al. Isatin, an endogenous monoamine oxidase inhibitor, triggers a dose and time dependent switch from apoptosis tonecrosis in human neuroblastoma cells [J ]. Neurochem Int, 2005, 47(3): 216.
9Okajima E, Thorgeirsson UP. Different regulation of vascular endothelial growth factor expression by the ERK and p38 kinase pathways in v - ras, v - raf, and v-myc transformed cells [J ] . Biochem Biophys Res Commun, 2000, 270(1):108.
10Harrisonl C, Verstovsek S, Mcmullin MF, et al. Janus ki- nase inhibition and its effect upon the therapeutic land- scape for myelofibrosis: from palliation to cure[J]. Br J Haematol, 2012,157(4) : 426.
